KSHV ASSOCIATED MULTICENTRIC CASTLEMAN DISEASE
Clinical trials for KSHV ASSOCIATED MULTICENTRIC CASTLEMAN DISEASE explained in plain language.
Never miss a new study
Get alerted when new KSHV ASSOCIATED MULTICENTRIC CASTLEMAN DISEASE trials appear
Sign up with your email to follow new studies for KSHV ASSOCIATED MULTICENTRIC CASTLEMAN DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for rare HIV-Linked cancer
Disease control OngoingThis early-phase trial tested whether combining two anti-cancer drugs, pomalidomide (taken as a pill) and liposomal doxorubicin (given through an IV), is safe and tolerable for people with advanced or hard-to-treat Kaposi sarcoma. The study enrolled 62 adults, including those wit…
Matched conditions: KSHV ASSOCIATED MULTICENTRIC CASTLEMAN DISEASE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Hidden bone loss: HIV and cancer patients under the scanner
Knowledge-focused OngoingThis study looks at why people with HIV and certain cancers caused by KSHV (Kaposi sarcoma herpesvirus) may lose bone density faster. Researchers will review past CT scans and health records from 40 adults treated at the NIH between 2005 and 2020. The goal is to find factors link…
Matched conditions: KSHV ASSOCIATED MULTICENTRIC CASTLEMAN DISEASE
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC